Verschoor, Y. L., van de Haar, J., van den Berg, J. G., van Sandick, J. W., Kodach, L. L., van Dieren, J. M., . . . Chalabi, M. (2024). Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: The phase 2 PANDA trial. Nature medicine, 30(2), 519-530. https://doi.org/10.1038/s41591-023-02758-x
Chicago-Zitierstil (17. Ausg.)Verschoor, Yara L., et al. "Neoadjuvant Atezolizumab Plus Chemotherapy in Gastric and Gastroesophageal Junction Adenocarcinoma: The Phase 2 PANDA Trial." Nature Medicine 30, no. 2 (2024): 519-530. https://doi.org/10.1038/s41591-023-02758-x.
MLA-Zitierstil (9. Ausg.)Verschoor, Yara L., et al. "Neoadjuvant Atezolizumab Plus Chemotherapy in Gastric and Gastroesophageal Junction Adenocarcinoma: The Phase 2 PANDA Trial." Nature Medicine, vol. 30, no. 2, 2024, pp. 519-530, https://doi.org/10.1038/s41591-023-02758-x.